Author: Jane Edwards|| Date Published: April 13, 2022
Oracle (NYSE: ORCL) has once again extended its tender offer of $95 in cash per share to buy all outstanding shares of common stock of health information technology company Cerner (Nasdaq: CERN) to provide more time to satisfy the remaining conditions.
Oracle agreed to acquire Cerner for approximately $28.3 billion through an all-cash tender offer in late December and both parties now expect the tender offer to expire on May 11, Oracle said Wednesday.
The tender offer, which was previously set to expire on April 13, remains subject to approvals under foreign direct investment and foreign competition laws and may be further extended in accordance with the merger deal and the Securities and Exchange Commission’s rules and regulations.
Oracle said approximately 11.5 percent of Cerner’s outstanding shares had been tendered as of April 8, Friday.
In February, Oracle announced the expiration of the waiting period under the Hart-Scott-Rodino Antitrust Improvements Act of 1976 for its proposed acquisition of Cerner.
Brian Meyer, federal field chief technology officer at Axonius Federal, said cybersecurity asset management could help government agencies make dozens…
“Technology transformation company Red River has acquired Invictus International Consulting to expand its cybersecurity and enterprise modernization capabilities to support…
Synergy ECP, a software engineering, cybersecurity and systems engineering services provider, has acquired NetServices, a company offering secure, mission-focused technology services. The…
Precision Aerospace & Defense Group and FACT II Acquisition, a special purpose acquisition company, have signed a definitive business combination agreement to…
LMI has announced the acquisition of intellectual property and advanced capabilities to broaden its in-transit visibility and asset tracking services for…
